There is evidence showing decreased mucosal inflammation of the Bacteroides ovatus ATCC 8384 monotherapy in marine colitis model (Ihekweazu et al., 2019) and promotion of IL‐22 production via dendritic cell differentiation (Ihekweazu et al., 2021). Here, IL22 is linked to colitis.